Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses. [PDF]
Engbers PAM +6 more
europepmc +1 more source
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomas. [PDF]
Grassi I +15 more
europepmc +1 more source
Pancreatic Neuroendocrine Tumors: From Benchside to Surgical Treatment. [PDF]
Conzo G +9 more
europepmc +1 more source
Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. [PDF]
Yu R, Gardner L, Salavati A, Bahri S.
europepmc +1 more source
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study. [PDF]
Fricke JG +14 more
europepmc +1 more source
Medical Management of Well-Differentiated Pancreatic Neuroendocrine Tumors: From Conventional Therapies to Emerging Strategies. [PDF]
Sung MJ, Park N.
europepmc +1 more source
Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial. [PDF]
Kolodziej M +29 more
europepmc +1 more source
Long-standing Large Nonfunctional Cardiac Paraganglioma. [PDF]
Schwedhelm TM, Das JP.
europepmc +1 more source
Intra-Arterial Radioligand Therapy in Brain Cancer: Bridging Nuclear Medicine and Interventional Neuroradiology. [PDF]
Sabuzi F +5 more
europepmc +1 more source

